By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
GENB insiders were on both sides of the trade this year. Buys came to roughly $150.3 million (six buyers), sales to $16,000 (one seller).
The largest purchase came from Nutritional Health LTP Fund General Partner LLC (Director), about $25 million. That includes C-suite money, which tends to get the most attention.
Zooming out by quarter: Last full quarter: net selling by insiders. Insiders bought in 1 of the last 7 full quarters. On the institutional side, 86 funds reported holding GENB at the end of Q2 2026, and more funds bought than sold.
Are insiders buying or selling GENB stock?
In the last 12 months Generate Biomedicines, Inc. insiders made open-market purchases worth about $150.3 million and sales worth about $16,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in GENB?
The most recent open-market insider trade in GENB was filed on 2026-09-03.
How many institutions own GENB?
86 investment managers reported holding GENB in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded GENB?
No congressional trades in GENB were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).